Company

SpringLeaf Therapeutics

Biotechnology Research Serious Disease and Elevate the Quality of Care for Patients. Springleaf’s Technology Is Based on the Convergence of Materials Science and Medicine and Is Designed to Enable and Differentiate Therapeutics. Springleaf Was Founded Based on Breakthrough Science at Mit and Is Backed by Leading Investors Including Sr. One 31 employees

Employees: 31

www.springleaftx.com LinkedIn

SpringLeaf Therapeutics Overview

Headquarters: Serious Disease and Elevate the Quality of Care for Patients. Springleaf’s Technology Is Based on the Convergence of Materials Science and Medicine and Is Designed to Enable and Differentiate Therapeutics. Springleaf Was Founded Based on Breakthrough Science at Mit and Is Backed by Leading Investors Including Sr. One
Website: www.springleaftx.com
Industry: Biotechnology Research
Employees: 31
Founded: 2007
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

actnano

About SpringLeaf Therapeutics

SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.